Skip to main content
Journal ArticleOPEN ACCESS

Successful treatment of a noninhibitory antibody‐mediated acquired factor X deficiency in a patient with marginal‐zone lymphoma

  • Meenhuis A
  • van Vliet R
  • Hudig F
  • et al.
Clinical Case Reports (2015) 3(7) 587-593
DOI: 10.1002/ccr3.294
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Prolonged clotting times were observed in a patient with spontaneous hemorrhage. Analysis showed severe factor X deficiency due to clearance by a noninhibitory antibody. Lymphadenopathy identified on imaging led to diagnosis of marginal B‐cell lymphoma. Treatment of lymphoma with rituximab and chlorambucil resulted in complete disappearance of the bleeding disorder.

Cite

CITATION STYLE

APA

Meenhuis, A., van Vliet, R., Hudig, F., Ypma, P. F., Schipperus, M. R., & Hollestelle, M. J. (2015). Successful treatment of a noninhibitory antibody‐mediated acquired factor X deficiency in a patient with marginal‐zone lymphoma. Clinical Case Reports, 3(7), 587–593. https://doi.org/10.1002/ccr3.294

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free